Download FREE Report Sample
Download Free sampleDengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.
Dengue Vaccines Market contains market size and forecasts of Dengue Vaccines in Global, including the following market information:
Global Dengue Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Dengue Vaccines market was valued at 412.2 million in 2021 and is projected to reach US$ 1010.9 million by 2028, at a CAGR of 13.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dengvaxia Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dengue Vaccines include Sanofi and Takeda etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dengue Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dengue Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Dengue Vaccines Market Segment Percentages, by Type, 2021 (%)
Dengvaxia
TAK-003
Others
Global Dengue Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Dengue Vaccines Market Segment Percentages, by Application, 2021 (%)
Public Sector
Private Sector
Global Dengue Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Dengue Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dengue Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Dengue Vaccines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Takeda
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
